These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 35141703)

  • 21. Role of the Gut Microbiota in Regulating Non-alcoholic Fatty Liver Disease in Children and Adolescents.
    Tokuhara D
    Front Nutr; 2021; 8():700058. PubMed ID: 34250000
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prolyl Endopeptidase Gene Disruption Improves Gut Dysbiosis and Non-alcoholic Fatty Liver Disease in Mice Induced by a High-Fat Diet.
    Jiang D; Zhang J; Lin S; Wang Y; Chen Y; Fan J
    Front Cell Dev Biol; 2021; 9():628143. PubMed ID: 34095107
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dextran Sulfate Sodium Salt-Induced Colitis Aggravates Gut Microbiota Dysbiosis and Liver Injury in Mice With Non-alcoholic Steatohepatitis.
    Shen B; Wang J; Guo Y; Gu T; Shen Z; Zhou C; Li B; Xu X; Li F; Zhang Q; Cai X; Dong H; Lu L
    Front Microbiol; 2021; 12():756299. PubMed ID: 34795650
    [No Abstract]   [Full Text] [Related]  

  • 24. Perinatal High-Salt Diet Induces Gut Microbiota Dysbiosis, Bile Acid Homeostasis Disbalance, and NAFLD in Weanling Mice Offspring.
    Guo Q; Tang Y; Li Y; Xu Z; Zhang D; Liu J; Wang X; Xia W; Xu S
    Nutrients; 2021 Jun; 13(7):. PubMed ID: 34206629
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dietary Intervention Reverses Fatty Liver and Altered Gut Microbiota during Early-Life Undernutrition.
    Bauer KC; Huus KE; Brown EM; Bozorgmehr T; Petersen C; Cirstea MS; Woodward SE; McCoy J; Hun J; Pamplona R; Ayala V; Finlay BB
    mSystems; 2020 Sep; 5(5):. PubMed ID: 32900869
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A botanical dietary supplement from white peony and licorice attenuates nonalcoholic fatty liver disease by modulating gut microbiota and reducing inflammation.
    Chen L; Kan J; Zheng N; Li B; Hong Y; Yan J; Tao X; Wu G; Ma J; Zhu W; Sheng L; Chen L; Li B; Zhong J; Du J; Li H
    Phytomedicine; 2021 Oct; 91():153693. PubMed ID: 34403877
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of Porphyromonas gingivalis infection on gut dysbiosis and resultant arthritis exacerbation in mouse model.
    Hamamoto Y; Ouhara K; Munenaga S; Shoji M; Ozawa T; Hisatsune J; Kado I; Kajiya M; Matsuda S; Kawai T; Mizuno N; Fujita T; Hirata S; Tanimoto K; Nakayama K; Kishi H; Sugiyama E; Kurihara H
    Arthritis Res Ther; 2020 Oct; 22(1):249. PubMed ID: 33076980
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Changes of gut microbiota during silybin-mediated treatment of high-fat diet-induced non-alcoholic fatty liver disease in mice.
    Li X; Wang Y; Xing Y; Xing R; Liu Y; Xu Y
    Hepatol Res; 2020 Jan; 50(1):5-14. PubMed ID: 31661720
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Oral Administration of Compound Probiotics Ameliorates HFD-Induced Gut Microbe Dysbiosis and Chronic Metabolic Inflammation via the G Protein-Coupled Receptor 43 in Non-alcoholic Fatty Liver Disease Rats.
    Liang Y; Liang S; Zhang Y; Deng Y; He Y; Chen Y; Liu C; Lin C; Yang Q
    Probiotics Antimicrob Proteins; 2019 Mar; 11(1):175-185. PubMed ID: 29353414
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gut microbiota dysbiosis in patients with non-alcoholic fatty liver disease.
    Shen F; Zheng RD; Sun XQ; Ding WJ; Wang XY; Fan JG
    Hepatobiliary Pancreat Dis Int; 2017 Aug; 16(4):375-381. PubMed ID: 28823367
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Beneficial effects of exercise on gut microbiota functionality and barrier integrity, and gut-liver crosstalk in an
    Carbajo-Pescador S; Porras D; García-Mediavilla MV; Martínez-Flórez S; Juarez-Fernández M; Cuevas MJ; Mauriz JL; González-Gallego J; Nistal E; Sánchez-Campos S
    Dis Model Mech; 2019 Apr; 12(5):. PubMed ID: 30971408
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of Probiotics in Non-alcoholic Fatty Liver Disease: Does Gut Microbiota Matter?
    Xie C; Halegoua-DeMarzio D
    Nutrients; 2019 Nov; 11(11):. PubMed ID: 31752378
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The severity of nonalcoholic fatty liver disease is associated with gut dysbiosis and shift in the metabolic function of the gut microbiota.
    Boursier J; Mueller O; Barret M; Machado M; Fizanne L; Araujo-Perez F; Guy CD; Seed PC; Rawls JF; David LA; Hunault G; Oberti F; Calès P; Diehl AM
    Hepatology; 2016 Mar; 63(3):764-75. PubMed ID: 26600078
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Absence of the Caspases 1/11 Modulates Liver Global Lipid Profile and Gut Microbiota in High-Fat-Diet-Induced Obese Mice.
    de Sant'Ana LP; Ribeiro DJS; Martins AMA; Dos Santos FN; Corrêa R; Almeida RDN; Eberlin MN; Maurice CF; Magalhães KG
    Front Immunol; 2019; 10():2926. PubMed ID: 31998283
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of an isoenergetic low Glycaemic Index (GI) diet on liver fat accumulation and gut microbiota composition in patients with non-alcoholic fatty liver disease (NAFLD): a study protocol of an efficacy mechanism evaluation.
    Al-Awadi A; Grove J; Taylor M; Valdes A; Vijay A; Bawden S; Gowland P; Aithal G
    BMJ Open; 2021 Oct; 11(10):e045802. PubMed ID: 34620653
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diammonium Glycyrrhizinate Protects against Nonalcoholic Fatty Liver Disease in Mice through Modulation of Gut Microbiota and Restoration of Intestinal Barrier.
    Li Y; Liu T; Yan C; Xie R; Guo Z; Wang S; Zhang Y; Li Z; Wang B; Cao H
    Mol Pharm; 2018 Sep; 15(9):3860-3870. PubMed ID: 30036479
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Caffeic acid prevents non-alcoholic fatty liver disease induced by a high-fat diet through gut microbiota modulation in mice.
    Mu HN; Zhou Q; Yang RY; Tang WQ; Li HX; Wang SM; Li J; Chen WX; Dong J
    Food Res Int; 2021 May; 143():110240. PubMed ID: 33992352
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Porphyromonas gingivalis is a risk factor for the development of nonalcoholic fatty liver disease via ferroptosis.
    Yao C; Lan D; Li X; Wang Y; Qi S; Liu Y
    Microbes Infect; 2023; 25(1-2):105040. PubMed ID: 35987459
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oral Administration of P. gingivalis Induces Dysbiosis of Gut Microbiota and Impaired Barrier Function Leading to Dissemination of Enterobacteria to the Liver.
    Nakajima M; Arimatsu K; Kato T; Matsuda Y; Minagawa T; Takahashi N; Ohno H; Yamazaki K
    PLoS One; 2015; 10(7):e0134234. PubMed ID: 26218067
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The role of the gut microbiota in NAFLD.
    Leung C; Rivera L; Furness JB; Angus PW
    Nat Rev Gastroenterol Hepatol; 2016 Jul; 13(7):412-25. PubMed ID: 27273168
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.